drugset / Trial / NCT01324869
Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME)
Phase 1/2
Completed
20 enrolled
Chengdu Kanghong Biotech Co., Ltd.
Teaching and Research Office of Health Statistics, Fourth Military Medical University · collabUniversity of Wisconsin, Madison · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to access the safety and efficacy of multiple injections of KH902 in patients with Diabetic Macular Edema (DME).
Timeline
- Start
- 2010-04
- Primary completion
- 2012-02
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Conbercept | Protein / enzyme biologic | 0.5 mg | Intravitreal |